United States - English - NLM (National Library of Medicine)

mylan institutional llc - cidofovir (unii: jil713q00n) (cidofovir anhydrous - unii:768m1v522c) - cidofovir anhydrous 75 mg in 1 ml - cidofovir is indicated for the treatment of cmv retinitis in patients with acquired immunodeficiency syndrome (aids). the safety and efficacy of cidofovir injection have not been established for treatment of other cmv infections (such as pneumonitis or gastroenteritis), congenital or neonatal cmv disease, or cmv disease in non-hiv-infected individuals. initiation of therapy with cidofovir injection is contraindicated in patients with a serum creatinine > 1.5 mg/dl, a calculated creatinine clearance ≤ 55 ml/min, or a urine protein ≥ 100 mg/dl (equivalent to ≥ 2+ proteinuria). cidofovir injection is contraindicated in patients receiving agents with nephrotoxic potential. such agents must be discontinued at least seven days prior to starting therapy with cidofovir injection. cidofovir injection is contraindicated in patients with hypersensitivity to cidofovir. cidofovir injection is contraindicated in patients with a history of clinically severe hypersensitivity to probenecid or other sulfa-containing medication

Canada - English - Health Canada

marcan pharmaceuticals inc - cidofovir (cidofovir dihydrate) - solution - 375mg - cidofovir (cidofovir dihydrate) 375mg - nucleosides and nucleotides

United States - English - NLM (National Library of Medicine)

heritage pharmaceuticals inc. d/b/a avet pharmaceuticals inc. - cidofovir (unii: jil713q00n) (cidofovir anhydrous - unii:768m1v522c) - cidofovir anhydrous 375 mg in 5 ml - initiation of therapy with cidofovir injection is contraindicated in patients with a serum creatinine >1.5 mg/dl, a calculated creatinine clearance ≤55 ml/min, or a urine protein ≥100 mg/dl (equivalent to ≥2+ proteinuria). cidofovir injection is contraindicated in patients receiving agents with nephrotoxic potential. such agents must be discontinued at least seven days prior to starting therapy with cidofovir injection. cidofovir injection is contraindicated in patients with hypersensitivity to cidofovir. cidofovir injection is contraindicated in patients with a history of clinically severe hypersensitivity to probenecid or other sulfa-containing medications. direct intraocular injection of cidofovir injection is contraindicated; direct injection of cidofovir has been associated with iritis, ocular hypotony, and permanent impairment of vision.

Israel - English - Ministry of Health

raz pharmaceutics ltd, israel - cidofovir as dihydrate - concentrate for solution for infusion - cidofovir as dihydrate 75 mg - cidofovir - cidofovir is indicated for the treatment of cmv retinitis in adults with acquired immunodeficiency syndrome (aids) and without renal dysfunction. it should be used only when other medicinal products are considered unsuitable.

United States - English - NLM (National Library of Medicine)

gilead sciences, inc. - cidofovir (unii: jil713q00n) (cidofovir anhydrous - unii:768m1v522c) - cidofovir anhydrous 75 mg in 1 ml - initiation of therapy with vistide is contraindicated in patients with a serum creatinine > 1.5 mg/dl, a calculated creatinine clearance ≤ 55 ml/min, or a urine protein ≥ 100 mg/dl (equivalent to ≥ 2+ proteinuria). vistide is contraindicated in patients receiving agents with nephrotoxic potential. such agents must be discontinued at least seven days prior to starting therapy with vistide. vistide is contraindicated in patients with hypersensitivity to cidofovir. vistide is contraindicated in patients with a history of clinically severe hypersensitivity to probenecid or other sulfa-containing medications. direct intraocular injection of vistide is contraindicated; direct injection of cidofovir has been associated with iritis, ocular hypotony, and permanent impairment of vision.

United States - English - NLM (National Library of Medicine)

ax pharmaceutical corp - cidofovir anhydrous (unii: 768m1v522c) (cidofovir anhydrous - unii:768m1v522c) -

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

tillomed pharma gmbh - cidofovir dihydrate 84,679 mg/ml - eq. cidofovir 75 mg/ml - concentrate for solution for infusion - 75 mg/ml - cidofovir dihydrate 84.679 mg/ml - cidofovir

United States - English - NLM (National Library of Medicine)

boston synthetics limited - cidofovir anhydrous (unii: 768m1v522c) (cidofovir - unii:jil713q00n) -

United States - English - NLM (National Library of Medicine)

bluebay shandong co.,ltd - cidofovir anhydrous (unii: 768m1v522c) (cidofovir anhydrous - unii:768m1v522c) -

United States - English - NLM (National Library of Medicine)

wuhan longke biotechnology co., ltd. - cidofovir (unii: jil713q00n) (cidofovir anhydrous - unii:768m1v522c) -